Presentation
9 March 2022 Dual PpIX and moxifloxacin fluorescence confocal imaging for brain tumor delineation​
Author Affiliations +
Abstract
5-ALA-based fluorescence-guided surgery (FGS) is a state-of-the-art treatment for brain tumors, but may miss areas due to its low sensitivity. To improve the sensitivity we developed dual PpIX and Moxifloxacin Fluorescence Confocal Imaging method that allows simultaneous imaging of 5-ALA and moxifloxacin by excitation with a single light source. This method verified by comparing confocal images in glioblastoma specimen. The distribution of cells expressing 5-ALA and moxifloxacin fluorescence signals showed the same correlation. In large-area tumor sample images, PplX showed differences in signal intensity, but moxifloxacin was constant. These results show the potential to improve sensitivity than with 5-ALA alone.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Seonghan Kim, Seunghun Lee, Kihean Kim, Eui Hyun Kim, Kyung Hwa Lee, and Chulmin Joo "Dual PpIX and moxifloxacin fluorescence confocal imaging for brain tumor delineation​", Proc. SPIE PC11949, Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems XX, PC1194907 (9 March 2022); https://doi.org/10.1117/12.2610940
Advertisement
Advertisement
KEYWORDS
Luminescence

Tumors

Confocal microscopy

Brain

Neuroimaging

Surgery

Microscopes

Back to Top